Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

Carestream’s Preclinical in Vivo Imaging Business to Be Acquired by Bruker

By BiotechDaily International staff writers
Posted on 05 Oct 2012
Carestream Health (Rochester, NY, USA) and Bruker Corp. (Billerica, MA, USA) have entered into an agreement for Bruker to purchase the preclinical in vivo imaging equipment product range and related assets from Carestream’s molecular imaging business. Financial terms of the agreement are not being disclosed.

Carestream will retain the remaining assets of its molecular imaging business, including its life science X-ray film product lines and its Gel Logic and Image Station in vitro imaging equipment-product range. Carestream will continue operating its life science X-ray film business, and will continue to support its in vitro product customers with service and parts. New production of its Gel Logic and Image Station in vitro products will be discontinued.

Dr. Werner Maas, president of Bruker BioSpin Corp., commented, “We are excited about adding Carestream’s in vivo imaging systems to our preclinical imaging product portfolio. We believe that Carestream’s optical molecular imaging product line will complement our other preclinical solutions, presently consisting of magnetic resonance imaging [MRI], magnetic particle imaging [MPI] and X-ray micro computed tomography [microCT]. We also welcome the talented Carestream in vivo employees to Bruker, and look forward to their contributions.”

Carestream Health is a worldwide provider of dental and medical imaging systems and healthcare information technology (IT) solutions; X-ray film and digital X-ray systems for nondestructive testing; and sophisticated materials for the precision films and electronics markets.

Bruker Corp. is a provider of scientific instruments and solutions for molecular and materials research, as well as for industrial and applied analysis.

Related Links:
Carestream Health
Bruker



Channels

Genomics/Proteomics

view channel
Image: Bacteriophage EFDG1 visualized by transmission electron microscopy (TEM) at a magnification of 20,000–30,000 times. Note that some phages are still bound to remains of the dead bacteria (Photo courtesy of the Hebrew University of Jerusalem).

Bacteriophage Therapy Eliminates Multidrug Resistant Bacterial Infections

Bacteriophage therapy has been shown to be an effective approach for treating infections caused by drug-resistant strains of the bacterium Enterococcus faecalis. E. faecalis, a bacterium inhabiting... Read more

Drug Discovery

view channel
Image: Molecular model of the protein Saposin C (Photo courtesy of Wikimedia Commons).

Nanovesicles Kill Human Lung Cancer Cells in Culture and in a Mouse Xenograft Model

Nanovesicles assembled from the protein Saposin C (SapC) and the phospholipid dioleoylphosphatidylserine (DOPS) were shown to be potent inhibitors of lung cancer cells in culture and in a mouse xenograft model.... Read more

Biochemistry

view channel

Possible New Target Found for Treating Brain Inflammation

Scientists have identified an enzyme that produces a class of inflammatory lipid molecules in the brain. Abnormally high levels of these molecules appear to cause a rare inherited eurodegenerative disorder, and that disorder now may be treatable if researchers can develop suitable drug candidates that suppress this enzyme.... Read more

Lab Technologies

view channel
Image: The FLUOVIEW FVMPE-RS Gantry microscope (Photo courtesy of Olympus).

New Multiphoton Laser Scanning Microscope Configurations Expand Research Potential

Two new configurations of a state-of-the-art multiphoton laser scanning microscope extend the usefulness of the instrument for examining rapidly occurring biological events and for obtaining images from... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.